MMV1802994

ID: ALA5309456

Chembl Id: CHEMBL5309456

Max Phase: Preclinical

Molecular Formula: C25H32N4O2

Molecular Weight: 420.56

Associated Items:

Names and Identifiers

Canonical SMILES:  O[C@H](COc1ccccc1CNCc1cc(-c2ccccc2)[nH]n1)CN1CCCCC1

Standard InChI:  InChI=1S/C25H32N4O2/c30-23(18-29-13-7-2-8-14-29)19-31-25-12-6-5-11-21(25)16-26-17-22-15-24(28-27-22)20-9-3-1-4-10-20/h1,3-6,9-12,15,23,26,30H,2,7-8,13-14,16-19H2,(H,27,28)/t23-/m0/s1

Standard InChI Key:  KWDKYLRHVJNHMX-QHCPKHFHSA-N

Alternative Forms

  1. Parent:

    ALA5309456

    ---

Associated Targets(Human)

HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 420.56Molecular Weight (Monoisotopic): 420.2525AlogP: 3.59#Rotatable Bonds: 10
Polar Surface Area: 73.41Molecular Species: BASEHBA: 5HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 11.52CX Basic pKa: 8.80CX LogP: 3.29CX LogD: 1.80
Aromatic Rings: 3Heavy Atoms: 31QED Weighted: 0.47Np Likeness Score: -1.46

References

1. Bosc N, Felix E, Gardner JMF, Mills J, Timmerman M, Asveld D, Rensen K, Mukherjee P, Das R, Chenu E, Besson D, Burrows JN, Duffy J, Laleu B, Guantai EM, Leach AR..  (2023)  MAIP: An Open-Source Tool to Enrich High-Throughput Screening Output and Identify Novel, Druglike Molecules with Antimalarial Activity.,  14  (12): [PMID:38116432] [10.1021/acsmedchemlett.3c00369]

Source

Source(1):